The Drugs Controller General of India declared on Sunday that the vaccines to combat coronavirus developed by the Serum Institute of India and Bharat Biotech were approved for restricted use in an Emergency situation. Serum Institute of India has produced Covishield, while, Bharat Biotech has developed Covaxin.
“After adequate Examination, CDSCO has decided to accept the recommendations of the Expert Committee and accordingly, vaccines of M/s Serum and M/s Bharat Biotech are being approved for restricted use in an Emergency situations,” the Drugs Controller General of India said while addressing the media. The vaccines will have to be taken in Two doses and have to be stored at Two to Eight degrees, DGCI said.